Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III ...
Background Delays in performing urgent coronary artery bypass graft (CABG) surgery are increasing across the UK, with ...
Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk ...
Background Patients with heart failure (HF) and severe mitral regurgitation (MR) have poor outcomes. Early identification ...
Background Secondary prevention is critical for patients with established atherosclerotic cardiovascular diseases (ASCVD).
Background The limited literature provides minimal information on clinical outcomes among patients undergoing percutaneous coronary intervention (PCI) under different healthcare funding systems, ...
Background Anticoagulation non-adherence is attributed to myriad factors in patient populations across the world. While direct oral anticoagulants (DOACs) have demonstrated several clinical advantages ...
Aims Heart failure (HF) often coexists with chronic kidney disease (CKD), impacting prognosis. This study aims to evaluate ...
Introduction Ischaemic heart disease (IHD) remains a leading cause of morbidity and mortality worldwide and poses an ...
APCU25CR28 Navigating dual diagnosis: case report of amyloid transthyretin (ATTR) cardiac amyloidosis and amyloid light-chain (AL) (13 February, 2026) ...
Introduction Cardiac MRI (CMRI) is an important investigation in cases of unclear cause of sudden cardiac arrest (SCA). It demonstrates diagnostic utility in assessing reversibility and tissue scar ...
Background Heart failure (HF) readmission and mortality rates remain high among HF patients. Improved and robust risk prediction models for better monitoring, informed decision-making, targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results